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Introduction 
Objective: To evaluate ultrasound measurement of Kaposi's sarcoma (KS) tumour 
volume for follow-up during therapy. Two-dimensional evaluation of size and 
description of gross alteration (for example, colour, nodularity, resolution) was used 
to assess treatment of KS. Flattening of palpable cutaneous KS lesions during anti-KS 
therapy has not been quantified objectively by a reliable method. 
Methods: In six patients with advanced AIDS and KS, a total of 17 cutaneous lesions 
were evaluated prospectively by ultrasound and surface measurements. KS lesions were 
examined histologically before and after 12 weeks of chemotherapy with liposomal 
doxorubicin. 
Results: In comparison with size reduction, volume measurement showed a more 
pronounced reduction of tumour volume. The mean tumour volume was reduced 
by 94% from 451 mm3 ± 655 mm3 to 66 mm3 ± 165 mm3 at week 12 (P < 0.001). 
Histological evaluation of lesions no longer detectable by ultrasound after therapy 
showed abundant siderophages but no increase in spindie cells and no mitoses. 
Conclusions: Our findings suggest that ultrasound is a useful method with which to 
follow growth and remission of cutaneous KS. In contrast, pigmentation due to iron 
deposition is unaffected by chemotherapy because, despite histological remission, 
pigmentation can persist. Though ultrasound cannot replace histologic evaluation for 
complete response, we suggest the use of ultrasound assessment, thus introducing a 
more objective criterion than subjective rating of nodularity. 
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Cutaneous Kaposi's sarcoma (KS) is a nodular tumour 
of dark appearance. Pigmentation is caused by a high 
density of capillaries and by intracutaneous iron depo-
sition [1]. To assess the efficacy of treatment for KS, 
two-dimensional evaluation of size (mm2) is used as 
well as description of gross alteration (for example, 
colour, nodularity, resolution). The heterogeneity of 
recruited subjects and lack of consistent response cri-
teria make it difficult to compare studies of therapy for 
KS. The definition recommended by the AIDS Clinical 
Trial Group (ACTG) for a complete response requires 
histological documentation of the absence of malig-
nant cells in remaining pigmented areas [2] . Complete 
remission with restitution of normally coloured skin is 
achieved by ehemotherapy in only a small proportion 
of lesions, and haemosiderin deposits may remain vis-
ible even when KS has otherwise resolved histologi-
eally. 
Flattening of palpable cutaneous KS lesions during 
anti-KS therapy has not been quantified objectively by 
a reliable method. In an attempt to improve staging, 
we evaluated the use of ultrasound for measurement 
of tumour volume. Cutaneous Kaposi lesions show a 
characteristic sonographie pattern of low echogenicity 
in contrast to the hyperechoic surrounding subcutis. 
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Thus, three-dimensional measurement of Kaposi le-
sions results in high accuracy for determination of 
tumour volume in follow-up evaluations. 
Subjects and methods 
In a Phase I/II open trial we assessed dosage, efficacy 
and safety of intravenously administered liposomal 
doxorubicin in patients with advanced KS [3 J. We in-
troduced the parameter 'tumour volume' as assessed 
by sonographic measurement. Between November 
1991 and June 1992, 32 male homosexual AIDS pa-
tients with advanced biopsy-confirmed KS were en-
rolled into the study (mean age, 38 years). Of these, 
30 were caucasian and two were of Hispanic origin. 
Twenty-eight patients had KS stage III or N according 
to the staging classification proposed by Mitsuyasu et 
al. [4J. Four patients had KS stage IIB with marked 
edema. Intravenous lipsomal doxorubicin (Doxilot , 
Liposomal Technology, Manlo Park, California, USA) 
at doses of 10, 20 and 40 mglm2 was administered to 
10, 19 and three patients every 2 weeks, respectively. 
In each patient target lesions were defined and fol-
lowed two-dimensionally during the trial. Six consecu-
tive patients were selected for prospective additional 
ultrasound evaluation. A sampie size of 17 lesions 
in six patients appeared sufficient for detection of 
differences between two- and three-dimensional meas-
urement of KS lesions. Tumour status of those patients 
according to the ACTG criteria was TI 11 SI in five cases 
and T 010S1 in one patient. 
After verbal informed consent, six consecutively re-
cruited patients were enrolled for ultrasound meas-
urement in January 1992. The selection criteria for KS 
lesions were nodularity and accessibility. Lesions were 
clearly nodular and technically accessible by the ultra-
sound transducer were selected for each patient. Acral 
lesions, intertriginous lesions and lesions < 0.5 cm in 
diameter were excluded. 
Each of the measurements at baseline and every 4 
weeks thereafter included two-dimensional visible size 
of pigmentated KS surface area, three-dimensional de-
termination of tumour volume by ultrasound examina-
tion and colour-slide photographic documentation of 
identical lesions. 
Ultrasound was performed using a 7.5 Megahertz lin-
ear transducer (Advanced Technology Laboratories 
Ltd, Seattle, Washington, USA; ULTRAMARK 5, Solin-
gen, Germany). Sonomorphological characteristics of 
cutaneous KS lesions are low echogenicity, compared 
with the hypereochoic surrounding subcutaneous tis-
sue, and relative homogenicity. Cutaneous KS lesions 
do not exhibit a clearly definable demarcation line. 
However, the border between subcutis and tumour 
is a zone of approximately 3 mm in which the tran-
sition from high to low echogenicity is seen. A central 
point in the transition area was chosen for measure-
ment as a surrogate for a clear demarcation line (Fig. 
1). Longitudinal and cross measurement was taken at 
the site of the greatest diameter of each lesion (Fig. 
2). Volumes were computed according to the formula 
for approximation of ellipsoids [(length x width x 
thickness)/2). 
Fig. 1. Diagram of eharaeteristie sonographie appearanee of eu-
taneous Kapoli's sareoma (KS) as depieted by 7.5 MHz linear 
transdueer. H, highly eehogenie surrounding subeutis; T, trans-
ition zone from high to low eehogenieity; L, low eehogenieity of 
KS. 
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Fig. 2. Sehematie diagram of measurement proeedure using the 
approximation for ellipsoid struetures. L, length; TH, thiekness; W, 
width. 
Ultrasound evaluations were performed by three dif-
ferent examiners (JRB, MH, and SS). Measurements 
obtained were comparable. To avoid systematic errors 
due to inter-individual differences, follow-up exami-
nations were performed by the same examiner who 
documented the baseline volume. 
In three out of the six patients, additional post-ther-
apy punch biopsies were taken from those cutaneous 
KS that had been followed by ultrasound examina-
tion. For histological examination, sections of forma-
lin embedded material were stained with haematoxylin 
and eosin, Elastica van Giesson and Berliner-Blau iron 
staining. 
Statistical analysis was performed by analysis of vari-
ance and Student's t-test. 
Results 
At week 12, after six cycles of liposomal doxoru-
bicine, there was a visible reduction of KS size 
by 26% from 288 mm2 ± 354 mm2 at baseline to 
210 mm2 ± 296 mm2 (p< 0.05, by t-test for paired 
sampies ). Visible response was documented by pho-
tographs showing a flattening of tumour lesions that 
appeared nodular prior to therapy (Fig. 3a versus Fig. 
3b). 
Fig. 3. Kaposi's sareoma (KS) lesion before and at week 12 of 
ehemotherapy with liposomal doxorubiein. (a) A c1early nodular 
KS lesion, whieh appears flattened after therapy (b). 
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Fig. 4. Reduetion of Kaposi's sareoma (KS) size (.) and volume 
(T) du ring ehemotherapy with liposomal doxorubicin at baseline 
and weeks 4, 8 and 12. While two-dimensional measurement of 
size does not show further reduetion after week 4, tumour vol-
urne, as determined by ultrasound, reveals a signifieant reduetion 
at eaeh interval. 'p < 0.05 versus baseline and versus week 4, 
tp< 0.05 versus baseline, tp< O.OOS versus baseline, §P < 0.001 
versus baseline and P< 0.01 versus week 8. 
Determination of tumour volume by ultrasound re-
vealed a reduction by 94% from 451 mm3 ± 655 mm3 
to 66mm3 ± 165mm3 (p< 0.001) at week 12. The 
mean volume at week 4 (225 mm3 ± 401 mm3) and 
KS volume and ultrasound Bogner et al. 1083 
Fig. 5. Sonographie examination of the Kaposi's sareoma lesion 
depieted in Fig. 3. (a) Tumour length and thiekness is indieated 
by + -- + and x -- x. (b) After therapy, the tumour is no 
longer detectab le by ultrasound. 
week 8 (115 mm3 ± 196mm3) was significantly re-
duced, compared with baseline (p < 0.05). Reduction 
of volume from weeks 4 to 8, and from weeks 8 to 12 
was significant, as shown in Fig. 4 (p< om). Figure 
5 shows two representative ultrasound images of the 
lesion depicted in Fig. 3, prior to and after therapy. 
Histological examinations at baseline showed an in-
creased number of irregular-shaped and sometimes 
dilated vessels in all levels of the dermis, which were 
lined by thin endothelial cells as weil as spindle-shaped 
cells in short fascicles. Perivascular plasma cells were 
noted and siderophages were found in abundance 
(Fig. 6a). 
After therapy, biopsies were obtained in three patients 
targeting the identical site that had been followed-up 
clinically (Fig. 3b) and by ultrasound (Fig. 5b). 
The biopsies taken after 12 weeks of treatment with 
liposomal doxorubicin showed a slightly increased 
number of inconspicuous and sometimes irregular-
shaped thin-walled vessels, lined by flat cells without 
mitoses or marked cytologic atypia in the upper half 
of the reticular dermis around the superficial and peri-
adnexal vascular plexus. No increase in the number of 
spindIe cells and clefts between collagen bundles was 
seen, but abundant siderophages and a slight fibrosis 
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Fig. 6. (a) Histology of a Kaposi's sareoma (KS) exeided from the 
same patient shown in Figs 3 and 5 prior to therapy; plaque stage 
of KS (haematoxylin and eosin x 250). (b) Histologie pieture of the 
lesion depieted in Figs 3b and Sb after therapy. In the lower half 
of the retieular dermis there are some siderophages and a slight 
fibrosis, but no spindie eells (haematoxylin and eosin x 150). 
were found in the lower half of the reticular dermis 
(Fig. 6b). 
Discussion 
Measurement of KS surface in two (visible) dimen· 
sions suggests minor reduction in size while sono-
graphie evaluation might indicate extensive remission. 
Since a haemosiderin deposits in the skin may remain 
visible for extended periods of time, despite success-
ful treatment of tumour cells, sonographie assessment 
appears more appropriate. The response criteria for 
KS evaluation developed by the Oncology Commit-
tee of ACTG recommend that the character of KS 
lesions is noted and evaluated [2]. Instead of using 
a grading of 'nodularity', which reHes on the personal 
judgement of the investigator, we sought to identify a 
more objective method of measurement. Ultrasound 
has been proposed as a harmless diagnostic aid to 
dinical examination of proliferative vascular lesions 
of the skin [5], such as lymphangiomas and hae-
mangiomas. Betti et al. [5] reported a 'mixed sono-
graphic structure with ill-defined margins' using high 
resolution ultrasonography with 20 MHz transducers. 
However, our experience of using a linear 7.5 MHz 
transducer showed that discrimination of KS tumours 
and surrounding subcutis is adequate although there 
is no dear demarcation of the tumour. Thus, deter-
mination of tumour volume in the natural course of 
KS or tumour regression during chemotherapy can be 
performed with sufficient reHability. However, further 
prospective analysis of inter-individual reproducibility 
of ultrasound examinations is necessary and ongoing 
at present. 
Our findings suggest that ultrasound is a useful 
method for follow-up of growth and remission of cu-
taneous KS. Moreover, ultrasound evaluation is more 
dosely related to the effect of chemotherapy in the re-
mission of KS, showing a reduction in tumour volume 
that can be histologically proven by lack of tumour 
cells. In contrast, pigmentation due to iron deposition 
is not affected by chemotherapy and is an unreliable 
parameter of its efficacy. 
Ultrasound examination can only be applied to a lim-
ited number of lesions, and tumour response cannot 
be based solelyon one to three lesions. However, his-
tologie examination can be performed on only one le-
sion and still confirm a response. The assessment of 
total tumour burden, and the appearance of new le-
sions and the visceral disease must also be evaluated. 
In general, siderophages are not abundant in macules 
or patches of KS [1]. The lesions seen before treat-
ment showed clinical features of nodularity and his-
tological features characteristic of the plaque stage 
of KS, combining the structure of patch and nodu-
lar lesions [6]. On lesions that were clearly nodular 
prior to therapy (dinically and as determined by ultra-
sound), punch biopsy was performed after treatment. 
The histologie features of early patch stages of KS were 
detectable. Nevertheless, these lesions showed an in-
creased number of siderophages in the dermis as well 
as slight fibrosis. Thus, the response detected by ultra-
sound (shrinking of volume to zero) was confirmed 
histologically after therapy. 
According to the ACTG's recommendation [2] histo-
logical absence of malignant cells is required for a 
complete response diagnosis. However, biopsy prior 
to and after a trial is not readily obtainable and in-
dudes an invasive procedure. Ultrasound measure-
ment and documentation of volume reduction is thus 
an easily appliable alternative. In patients in whom skin 
biopsy cannot be obtained (no consent, contra-indi-
cations), ultrasound may provide an alternative meas-
urement. However, histological evaluation for confir-
mation of complete response cannot be replaced by 
ultrasound. 
We suggest that clinical trials use ultrasound assess-
ment of remission of cutaneous KS to evaluate new 
treatment regimens. 
References 
1. GoTIUEB GJ, ACKERMAN AB: Kaposi's Sarcoma: Text and Atlas. 
Philadelphia: l.ea and Febiger; 1988. 
2. KROWN SE, METROKA C, WERNZ JC: Kaposi's sarcoma in the 
acquired immune deficiency syndrome: a proposal for uni-
form evaluation, response, and staging criteria. ] Clin Oncol 
1989, 7:1201-1207. 
3. GOEBEL FO, UEBSCHWAGER M, HElD M, ET AL.: Successful treat-
ment of advanced Kaposi sarcoma (KS) with liposomal 
doxorubicin - short-term observations. VIII International 
4. 
5. 
6. 
KS volume and ultrasound Bogner et al. 1085 
Conference on AIDS/III STD World Congress. Amsterdam, July 
1992 [abstract PoB3108j. 
MITSUYASU RT, JEREMY MG, TAYLOR G, GIAPSY J, FAHEY JL: 
Heterogeneity of epidemie Kaposi's sarcoma. Implications 
for therapy. Cancer 1986, 57:1657-1665. 
BETII R, NESSI R, BLANC M, ET AL.: Ultrasonography of pro-
liferative vascular lesions of the skin. ] Dermatal 1990, 
17:247-251. 
MuRPHY GF, EIDER OE: Non-me1anotic tumors of the skin. 
In Atlas ofTumor Pathology, 3rd edn. Washington, OC: Armed 
Forces Institute of Pathology; 1991. 
